The inhibitory functions of checkpoints could be reversed by anti-angiogenic agents, as when VEGF is blocked, tumor blood vessels decrease and tumor tissue hypoxia is induced, which in turn activates hypoxia-inducible factor (HIF-1α), and promotes cytokine production to activate CD8+ T cells 43-45. This evidence concerns the gene HIF1A and neoplasm.